azelastine has been researched along with 2019 Novel Coronavirus Disease in 1 studies
azelastine: azeptin is azelastine hydrochloride; structure; eye drop formulation effective in relieving symptoms of allergic conjunctivitis; do not confuse with 5-loxin which is an extract of Boswellia
azelastine : A phthalazine compound having an oxo substituent at the 1-position, a 1-methylazepan-4-yl group at the 2-position and a 4-chlorobenzyl substituent at the 4-position.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Klussmann, JP | 1 |
Grosheva, M | 1 |
Meiser, P | 1 |
Lehmann, C | 1 |
Nagy, E | 1 |
Szijártó, V | 1 |
Nagy, G | 1 |
Konrat, R | 1 |
Flegel, M | 1 |
Holzer, F | 1 |
Groß, D | 1 |
Steinmetz, C | 1 |
Scherer, B | 1 |
Gruell, H | 1 |
Schlotz, M | 1 |
Klein, F | 1 |
de Aragão, PA | 1 |
Morr, H | 1 |
Al Saleh, H | 1 |
Bilstein, A | 1 |
Russo, B | 1 |
Müller-Scholtz, S | 1 |
Acikel, C | 1 |
Sahin, H | 1 |
Werkhäuser, N | 1 |
Allekotte, S | 1 |
Mösges, R | 1 |
1 trial available for azelastine and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
Early intervention with azelastine nasal spray may reduce viral load in SARS-CoV-2 infected patients.
Topics: COVID-19; Double-Blind Method; Humans; Nasal Sprays; SARS-CoV-2; Treatment Outcome; Viral Load | 2023 |